Respiratory Function and Dysphagia Therapy in CBS/PSP

Migration, Crosslink

📖

Respiratory Function and Dysphagia Therapy in CBS/PSP

active

wiki page Created: 2026-04-02T07:19:00 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-respiratory-dysphagia-

📖 Wiki Page

therapeutic2554 wordssynced 2026-04-02

Respiratory Function and Dysphagia Therapy in CBS/PSP

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Respiratory Function and Dysphagia Therapy in CBS/PSP</th>
</tr>
<tr>
<td class="label">Phase</td>
<td>CBS/PSP Effect</td>
</tr>
<tr>
<td class="label">Oral preparatory</td>
<td>Ideomotor apraxia, slowed transit</td>
</tr>
<tr>
<td class="label">Oral transit</td>
<td>Reduced tongue coordination, dysarthria</td>
</tr>
<tr>
<td class="label">Pharyngeal</td>
<td>Delayed pharyngeal trigger, reduced pharyngeal contraction</td>
</tr>
<tr>
<td class="label">Esophageal</td>
<td>Reduced peristalsis, UES dysfunction</td>
</tr>
<tr>
<td class="label">IDDSI Level</td>
<td>Description</td>
</tr>
<tr>
<td class="label">0</td>
<td>Thin</td>
</tr>
<tr>
<td class="label">1</td>
<td>Slightly thick</td>
</tr>
<tr>
<td class="label">2</td>
<td>Mildly thick</td>
</tr>
<tr>
<td class="label">3</td>
<td>Liquidised / Moderately thick</td>
</tr>
<tr>
<td class="label">4</td>
<td>Pureed / Extremely thick</td>
</tr>
<tr>
<td class="label">5</td>
<td>Minced & Moist</td>
</tr>
<tr>
<td class="label">6</td>
<td>Soft & Bite-Sized</td>
</tr>
<tr>
<td class="label">7</td>
<td>Regular</td>
</tr>
<tr>
<td class="label">Timepoint</td>
<td>Assessments</td>
</tr>
<tr>
<td class="label">Diagnosis</td>
<td>Baseline swallow screen (3-oz test), FOIS, respiratory exam, FVC, PCF</t

...

Respiratory Function and Dysphagia Therapy in CBS/PSP

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Respiratory Function and Dysphagia Therapy in CBS/PSP</th>
</tr>
<tr>
<td class="label">Phase</td>
<td>CBS/PSP Effect</td>
</tr>
<tr>
<td class="label">Oral preparatory</td>
<td>Ideomotor apraxia, slowed transit</td>
</tr>
<tr>
<td class="label">Oral transit</td>
<td>Reduced tongue coordination, dysarthria</td>
</tr>
<tr>
<td class="label">Pharyngeal</td>
<td>Delayed pharyngeal trigger, reduced pharyngeal contraction</td>
</tr>
<tr>
<td class="label">Esophageal</td>
<td>Reduced peristalsis, UES dysfunction</td>
</tr>
<tr>
<td class="label">IDDSI Level</td>
<td>Description</td>
</tr>
<tr>
<td class="label">0</td>
<td>Thin</td>
</tr>
<tr>
<td class="label">1</td>
<td>Slightly thick</td>
</tr>
<tr>
<td class="label">2</td>
<td>Mildly thick</td>
</tr>
<tr>
<td class="label">3</td>
<td>Liquidised / Moderately thick</td>
</tr>
<tr>
<td class="label">4</td>
<td>Pureed / Extremely thick</td>
</tr>
<tr>
<td class="label">5</td>
<td>Minced & Moist</td>
</tr>
<tr>
<td class="label">6</td>
<td>Soft & Bite-Sized</td>
</tr>
<tr>
<td class="label">7</td>
<td>Regular</td>
</tr>
<tr>
<td class="label">Timepoint</td>
<td>Assessments</td>
</tr>
<tr>
<td class="label">Diagnosis</td>
<td>Baseline swallow screen (3-oz test), FOIS, respiratory exam, FVC, PCF</td>
</tr>
<tr>
<td class="label">Every 3 months</td>
<td>Clinical swallow evaluation, cough strength (PCF), symptom review</td>
</tr>
<tr>
<td class="label">Every 6 months</td>
<td>FEES or VFSS if symptomatic, pulmonary function tests, ABG if indicated</td>
</tr>
<tr>
<td class="label">Annually</td>
<td>Full respiratory assessment including overnight oximetry</td>
</tr>
</table>

Parent page: [Personalized Treatment Plan](/therapeutics/personalized-treatment-plan-atypical-parkinsonism)

Respiratory dysfunction and dysphagia represent critical clinical challenges in Corticobasal Syndrome (CBS) and Progressive Supranuclear Palsy (PSP), significantly impacting both survival and quality of life. The prevalence of dysphagia approaches 80-90% in PSP[@warnecke2017], and aspiration pneumonia remains the leading cause of mortality, accounting for up to 50% of deaths in these conditions[@ferrucci2022]. This comprehensive guide covers the pathophysiology, assessment methods, therapeutic interventions, and prevention protocols for these life-threatening complications.

1. Pathophysiology of Respiratory and Swallowing Dysfunction

1.1 Neural Circuit Basis

The neural circuits governing respiration and swallowing share significant anatomical substrate with the brainstem regions most affected in CBS and PSP. Understanding this anatomical overlap explains why these complications develop in parallel and progress together.

Brainstem Involvement in CBS/PSP:

The neuropathological features of CBS and PSP directly compromise the neural structures essential for respiration and swallowing. The substantia nigra pars compacta suffers dopaminergic degeneration, which disrupts the modulation of brainstem motor control circuits. The pontine respiratory group (PRG) controls inhalation patterns, while the medullary dorsal and ventral respiratory groups coordinate the automatic breathing cycle. The nucleus tractus solitarius (NTS) serves as the primary integration center for swallow coordination, receiving sensory input from pharyngeal receptors and coordinating the motor output to hypoglossal, vagus, and glossopharyngeal nuclei[@shannon2020].

The pedunculopontine nucleus (PPN), located in the pontine tegmentum, plays dual roles in both respiration and gait control. Degeneration of the PPN in PSP contributes to the characteristic gait disturbance and also impairs the autonomic regulation of breathing during sleep, leading to nocturnal hypoventilation and sleep-disordered breathing.

1.2 Swallowing Physiology Breakdown

Swallowing involves four distinct phases, each requiring precise neural coordination. In CBS and PSP, dysfunction occurs across multiple phases due to the diffuse cortical and subcortical involvement.

The pharyngeal phase is particularly vulnerable in CBS/PSP because the brainstem structures controlling this automatic response (the dorsal swallowing group in the medulla) are directly affected by the neurodegenerative process. The delay in pharyngeal trigger creates a dangerous window where food or liquid can enter the airway before the protective closure of the larynx.

1.3 Respiratory Complications

Beyond swallowing, CBS and PSP produce progressive respiratory dysfunction through multiple mechanisms[@beyer2021]:

Diaphragmatic Dysfunction: The phrenic nerve nuclei may be affected, leading to weakness of the diaphragm and reduced inspiratory capacity. This manifests as orthopnea and reliance on accessory muscles for breathing.

Upper Airway Obstruction: Laryngeal dysfunction and vocal cord paralysis can cause stridor and obstructive sleep apnea patterns. The recurrent laryngeal branch of the vagus nerve may be compromised.

Central Hypoventilation: Brainstem involvement can impair the automatic respiratory drive, leading to Cheyne-Stokes breathing patterns and nocturnal hypoventilation, particularly in REM sleep.

Cough Impairment: Weak expiratory muscles and impaired glottic closure reduce the effectiveness of cough, compromising the ability to clear aspirated material or secretions.

2. Comprehensive Assessment

2.1 Clinical Swallowing Assessment

A systematic clinical assessment forms the foundation of dysphagia management. The following standardized tools provide quantitative measures of swallowing safety and efficiency:

Screening Tools:

The 3-oz water swallow test evaluates the patient ability to drink 3 oz (90 mL) of water continuously without stopping. The test is considered abnormal if the patient cannot complete the task, experiences coughing or throat clearing during or after the swallow, or demonstrates a wet/gurgly voice quality. A score of >10 seconds for completion suggests significant impairment.

The Toronto bedside swallowing screening test (TBSST) incorporates sequential swallowing of 5 mL water three times, followed by 5 mL water from a cup. The test assesses whether the patient can complete the sequence without symptoms and provides a pass/fail result indicating need for further evaluation.

The Functional Oral Intake Scale (FOIS) provides a seven-point ordinal scale ranging from nothing by mouth (1) to total oral diet with no restrictions (7). This scale tracks functional improvement or deterioration over time and helps guide treatment decisions, including the need for enteral feeding.

Cough Assessment:

The cough strength test using peak cough flow (PCF) offers a simple bedside measure of cough effectiveness. A PCF <270 L/min indicates reduced cough capacity and increased aspiration risk[@miles2023]. Values below 160 L/min suggest critical impairment requiring urgent intervention.

2.2 Instrumental Assessment

Fiberoptic Endoscopic Evaluation of Swallowing (FEES):

FEES represents the preferred instrumental assessment method for CBS/PSP due to its excellent tolerability and comprehensive evaluation capability[@mueller2021]. This procedure involves passing a flexible endoscope through the nasal passage to directly visualize the pharynx and larynx during swallowing.

FEES provides crucial information regarding:

Pharyngeal residue location and quantity (valleculae, pyriform sinuses)
Presence and timing of aspiration (before, during, or after swallow)
Secretion management and pooling
Sensitivity of the pharyngeal mucosa
Effectiveness of swallowing maneuvers

The penetration-Aspiration Scale (PAS) scores observed airway invasion from 1 (material does not enter the airway) to 8 (material enters the airway, passes below the vocal folds, and no effort is made to eject). Scores ≥3 indicate safety concerns requiring intervention.

Video-fluoroscopic Swallowing Study (VFSS):

VFSS provides dynamic radiographic imaging of all swallowing phases and is essential for comprehensive evaluation[@grassi2023]. This assessment quantifies:

Oral transit time (normal: <1 second)
Pharyngeal transit time (normal: <1 second)
Pharyngeal delay (normal: <200 ms)
Hyoid excursion extent
Upper esophageal sphincter opening width
Aspiration severity and timing
Residue quantification

VFSS enables testing of compensatory strategies in real-time, allowing the clinician to identify optimal techniques for individual patients.

2.3 Respiratory Assessment

Pulmonary Function Testing:

Spirometry provides objective measures of respiratory reserve. Forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) are the primary metrics. Values below 50% predicted indicate significant impairment and increased perioperative risk.

Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) assess respiratory muscle strength. MIP <30 cm H2O indicates inspiratory muscle weakness, while MEP <40 cm H2O indicates expiratory muscle weakness[@silva2022].

Peak cough flow (PCF) serves as the key functional measure. As noted, PCF <270 L/min indicates inadequate cough for airway protection.

Overnight Oximetry:

Nocturnal hypoxemia is common in CBS/PSP due to hypoventilation, obstructive events, or central apneas. Overnight pulse oximetry with continuous recording identifies significant desaturation events (SpO2 <88% for >5 minutes) that may require intervention.

Blood Gas Analysis:

Arterial blood gas (ABG) measurement provides direct assessment of CO2 retention and hypoxemia. Elevated PaCO2 (>45 mmHg) indicates respiratory failure requiring intervention.

3. Therapeutic Interventions

3.1 Compensatory Strategies

Diet Modification:

Modifying food and liquid consistency is the primary compensatory strategy for dysphagia. The International Dysphagia Diet Standardisation Initiative (IDDSI) framework provides a systematic approach:

Thickened liquids (nectar-thick, honey-thick, or pudding-thick) reduce aspiration risk by slowing liquid flow and giving more time for the swallow trigger. However, evidence suggests thickened liquids may increase residue in some patients, and individual response varies.

Postural Strategies:

Specific body positions can reduce aspiration risk:

The chin-tuck maneuver brings the epiglottis closer to the airway entrance, protecting the larynx. The patient flexes the neck approximately 45 degrees, bringing the chin toward the chest.

Head rotation to the weak side directs food flow away from the damaged pharynx and reduces aspiration risk on that side.

The 90-degree upright sitting position optimizes gravitational assistance for safe swallowing. Remaining upright for 30 minutes after meals prevents reflux and delayed aspiration.

3.2 Swallow Rehabilitation Exercises

Shaker Exercise (Head Lift):

The Shaker exercise targets suprahyoid muscle strengthening to improve upper esophageal sphincter (UES) opening. The patient lies supine and lifts the head to look at the toes, maintaining the position for 60 seconds, then repeating 3 times. This exercise should be performed twice daily for 8-12 weeks. Contraindications include cervical spine conditions, cardiac issues, and severe dysphagia.

Masako Maneuver:

The Masako maneuver involves placing the tongue between the teeth and swallowing to increase pharyngeal contraction. The patient holds the tongue position while attempting to swallow, which increases posterior pharyngeal wall movement. Recommended protocol: 10 repetitions, 3 times daily.

Mendelsohn Maneuver:

The Mendelsohn maneuver prolongs hyoid elevation during swallowing to extend UES opening time. The patient identifies the "hold" point during swallowing when the Adam's apple elevates, then deliberately maintains this position for 2-3 seconds before releasing. Practice with biofeedback (e.g., EMG or ultrasound) improves effectiveness.

Effortful Swallow:

The effortful swallow increases posterior pharyngeal pressure by having the patient swallow as hard as possible while squeezing the muscles. This technique improves pharyngeal clearance in patients with residue.

3.3 Neuromuscular Electrical Stimulation (NMES)

Neuromuscular electrical stimulation delivers electrical current to the muscles involved in swallowing, potentially improving muscle function and strength[@lazzaro2020]. Surface electrodes are placed on the skin over the submental muscles (mylohyoid, genioglossus) and the thyroid cartilage area (strap muscles).

Parameters typically include:

Frequency: 50-80 Hz
Pulse duration: 200-300 μs
On time: 5-10 seconds
Off time: 5-10 seconds
Treatment duration: 20-30 minutes
Frequency: 3-5 times per week for 4-6 weeks

Evidence for NMES efficacy in neurodegenerative conditions remains mixed, with some studies showing benefit for pharyngeal contraction and others showing minimal effect.

3.4 Respiratory Therapy

Respiratory Muscle Training (RMT):

Inspiratory muscle training using a pressure threshold device improves inspiratory strength in CBS/PSP[@silva2022]. The device provides resistance during inspiration, requiring the patient to generate sufficient negative pressure to open the valve.

Typical protocol:

Intensity: 30-50% of maximal inspiratory pressure (MIP)
Duration: 30 breaths, twice daily
Duration: 8-12 weeks for effect
Reassessment of MIP every 2-4 weeks to adjust intensity

Mechanical Insufflation-Exsufflation (MIE):

MIE applies positive pressure to inflate the lungs followed by rapid negative pressure to simulate a cough. This device is essential for patients with PCF <270 L/min who cannot generate adequate cough force[@miles2023].

Settings:

Inlation pressure: 30-40 cm H2O
Exsufflation pressure: -30 to -40 cm H2O
Cycle: 2-3 seconds per phase
3-5 cycles per session

Non-Invasive Ventilation (NIV):

For patients with hypercapnia (PaCO2 >45 mmHg) or nocturnal hypoventilation, non-invasive positive pressure ventilation (NIPPV) provides ventilatory support[@sutcliffe2023]. Bilevel positive airway pressure (BiPAP) with backup rate is typically used.

Indications for NIV:

PaCO2 >45 mmHg
Nocturnal SpO2 <88% for >5 minutes despite oxygen
Morning headache or daytime somnolence
Documented hypoventilation on sleep study

3.5 Aspiration Pneumonia Prevention

A comprehensive prevention strategy addresses multiple risk factors:

Positioning:

Maintain 90-degree upright positioning during meals
Remain upright for 30-60 minutes after eating
Use tilt-in-space chairs for patients who cannot maintain upright independently

Oral Care:

Perform oral hygiene twice daily with chlorhexidine 0.12% mouthwash
Remove and clean dentures daily
Professional dental cleaning every 6 months

Vaccination:

Pneumococcal vaccination (PCV20 or sequential PCV15/PPSV23)
Annual influenza vaccination
COVID-19 vaccination and boosters per current guidelines

Enteral Feeding Considerations:
For patients with FOIS ≤3 (unable to maintain adequate oral intake) or recurrent aspiration despite optimization, enteral feeding may be necessary. Options include:

Nasogastric tube: Short-term option, easily placed
Percutaneous endoscopic gastrostomy (PEG): Long-term option, placed endoscopically
Jejunal feeding: For patients with significant gastroparesis or reflux

The decision to place a feeding tube requires careful discussion with patients and families regarding goals of care, life expectancy, and quality of life implications.

4. Integrated Management Protocol

4.1 Monitoring Schedule

4.2 Multidisciplinary Team

Effective management requires coordination across multiple specialties:

Core Team:

Movement disorder neurologist: Medical management, disease-modifying considerations
Speech-language pathologist (SLP): Swallow assessment, rehabilitation, education
Pulmonologist: Respiratory assessment, NIV management
Dietitian: Nutritional status, diet modifications, supplementation

Supporting Team:

Occupational therapist: Positioning, adaptive equipment
Physical therapist: Mobility, respiratory function
Palliative care: Symptom management, goals of care, family support
Gastroenterologist: PEG placement, feeding management
Dentist: Oral health, denture management

4.3 Emergency Response Planning

Given the high risk of aspiration, emergency planning is essential:

For patients and caregivers:

Recognition of aspiration signs (coughing, choking, color change, fever)
Heimlich maneuver training
Emergency contact numbers
When to call emergency services

Healthcare team protocols:

Chest X-ray for suspected pneumonia
Broad-spectrum antibiotics for aspiration pneumonia
Airway protection if severe aspiration
Code status discussion

5. Cross-Links

[Section 113: Speech and Language Therapy](/therapeutics/section-113-speech-language-therapy-cbs-psp) — Dysarthria and communication interventions
[Section 249: LSVT Voice Therapy](/therapeutics/section-249-advanced-lsvt-voice-speech-therapy-cbs-psp) — Voice and respiratory coordination training
[Sleep Disorders in CBS/PSP](/therapeutics/sleep-disorders-cbs-psp) — Nocturnal respiratory dysfunction and sleep-disordered breathing
[Clinical Management Guide](/therapeutics/clinical-management-guide-cbs-psp) — Comprehensive care coordination
[PSP Speech and Swallowing Mechanisms](/mechanisms/psp-speech-swallowing-disorders) — Detailed pathophysiology
[Parkinson's Disease Dysphagia](/mechanisms/parkinson-disease-dysphagia) — Comparison with idiopathic PD
[Non-Invasive Brain Stimulation](/therapeutics/non-invasive-brain-stimulation-therapy) — Experimental approaches to swallow function

References

[Unknown, Dysphagia in progressive supranuclear palsy: prevalence and clinical correlates (2017)](https://pubmed.ncbi.nlm.nih.gov/28121384/)

[Unknown, Respiratory dysfunction in atypical parkinsonism (2020)](https://pubmed.ncbi.nlm.nih.gov/32822631/)

[Unknown, Fiberoptic endoscopic evaluation of swallowing in progressive supranuclear palsy and corticobasal syndrome (2021)](https://pubmed.ncbi.nlm.nih.gov/34330452/)

[Unknown, Respiratory muscle training in atypical parkinsonism: a randomized controlled trial (2022)](https://pubmed.ncbi.nlm.nih.gov/35067012/)

[Unknown, Cough augmentation in neurodegenerative disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37142389/)

[Unknown, Swallowing dysfunction in Parkinson's disease and atypical parkinsonism (2021)](https://pubmed.ncbi.nlm.nih.gov/33420792/)

[Unknown, Aspiration pneumonia in Parkinson's disease: risk factors and mortality (2022)](https://pubmed.ncbi.nlm.nih.gov/34996402/)

[Unknown, Video-fluoroscopic swallowing study in atypical parkinsonism (2023)](https://pubmed.ncbi.nlm.nih.gov/36782341/)

[Unknown, Dysphagia in Parkinson's disease: a systematic review (2012)](https://pubmed.ncbi.nlm.nih.gov/22212484/)

[Unknown, Respiratory complications in progressive supranuclear palsy (2021)](https://pubmed.ncbi.nlm.nih.gov/33495823/)

[Unknown, Non-invasive ventilation in atypical parkinsonism with respiratory failure (2023)](https://pubmed.ncbi.nlm.nih.gov/37258391/)

[Unknown, Neuromuscular electrical stimulation for dysphagia in atypical parkinsonism (2020)](https://pubmed.ncbi.nlm.nih.gov/32007782/)

[Unknown, Predictors of survival in progressive supranuclear palsy (2019)](https://pubmed.ncbi.nlm.nih.gov/31101472/)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Bacterial Enzyme-Mediated Dopamine Precursor Synthesis](/hypothesis/h-7bb47d7a) — 0.44 · Target: TH, AADC
[Purinergic Signaling Polarization Control](/hypothesis/h-0758b337) — 0.74 · Target: P2RY1 and P2RX7
[Mechanosensitive Ion Channel Reprogramming](/hypothesis/h-db6aa4b1) — 0.65 · Target: PIEZO1 and KCNK2
[Lipid Droplet Dynamics as Phenotype Switches](/hypothesis/h-7d4a24d3) — 0.57 · Target: DGAT1 and SOAT1
[CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — 0.79 · Target: CYP46A1
[Gamma entrainment therapy to restore hippocampal-cortical synchrony](/hypothesis/h-bdbd2120) — 0.77 · Target: SST
[Selective Acid Sphingomyelinase Modulation Therapy](/hypothesis/h-de0d4364) — 0.77 · Target: SMPD1
[Purinergic P2Y12 Inverse Agonist Therapy](/hypothesis/h-f99ce4ca) — 0.71 · Target: P2RY12

Related Analyses:

[4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) 🔄
[Astrocyte reactivity subtypes in neurodegeneration](/analysis/SDA-2026-04-01-gap-007) 🔄
[Lipid raft composition changes in synaptic neurodegeneration](/analysis/SDA-2026-04-01-gap-lipid-rafts-2026-04-01) 🔄
[TDP-43 phase separation therapeutics for ALS-FTD](/analysis/SDA-2026-04-01-gap-006) 🔄
[Synaptic pruning by microglia in early AD](/analysis/SDA-2026-04-01-gap-v2-691b42f1) 🔄

📖 View canonical wiki page →

Related Entities

therapeutics-respiratory-dysphagia-cbs-psp

▸Metadataorigin_type: v1_polymorphic_backfill

slug	therapeutics-respiratory-dysphagia-cbs-psp
kg_node_id	None
entity_type	therapeutic
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-ef8a2a458476
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'therapeutics-respiratory-dysphagia-cbs-psp'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

347

Outgoing

356

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Respiratory Function and Dysphagia Therapy in CBS/PSP

Respiratory Function and Dysphagia Therapy in CBS/PSP

Respiratory Function and Dysphagia Therapy in CBS/PSP

1. Pathophysiology of Respiratory and Swallowing Dysfunction

1.1 Neural Circuit Basis

1.2 Swallowing Physiology Breakdown

1.3 Respiratory Complications

2. Comprehensive Assessment

2.1 Clinical Swallowing Assessment

2.2 Instrumental Assessment

2.3 Respiratory Assessment

3. Therapeutic Interventions

3.1 Compensatory Strategies

3.2 Swallow Rehabilitation Exercises

3.3 Neuromuscular Electrical Stimulation (NMES)

3.4 Respiratory Therapy

3.5 Aspiration Pneumonia Prevention

4. Integrated Management Protocol

4.1 Monitoring Schedule

4.2 Multidisciplinary Team

4.3 Emergency Response Planning

5. Cross-Links

References

💬 Discussion

📗 Cite This Artifact

Respiratory Function and Dysphagia Therapy in CBS/PSP

Respiratory Function and Dysphagia Therapy in CBS/PSP

Respiratory Function and Dysphagia Therapy in CBS/PSP

1. Pathophysiology of Respiratory and Swallowing Dysfunction

1.1 Neural Circuit Basis

1.2 Swallowing Physiology Breakdown

1.3 Respiratory Complications

2. Comprehensive Assessment

2.1 Clinical Swallowing Assessment

2.2 Instrumental Assessment

2.3 Respiratory Assessment

3. Therapeutic Interventions

3.1 Compensatory Strategies

3.2 Swallow Rehabilitation Exercises

3.3 Neuromuscular Electrical Stimulation (NMES)

3.4 Respiratory Therapy

3.5 Aspiration Pneumonia Prevention

4. Integrated Management Protocol

4.1 Monitoring Schedule

4.2 Multidisciplinary Team

4.3 Emergency Response Planning

5. Cross-Links

References

Related Hypotheses

💬 Discussion